Gestational trophoblastic disease with pulmonary and cerebral metastasis: Can fluorodeoxyglucose positron emission tomography really detect cranial metastatic disease ? | Zendy

KUMBASAR Ulaş UYSAL | Zendy

Open Access

Gestational trophoblastic disease with pulmonary and cerebral metastasis: Can fluorodeoxyglucose positron emission tomography really detect cranial metastatic disease ?

Author(s) -

KUMBASAR Ulaş UYSAL

Publication year - 2016

Publication title -

ankara üniversitesi tıp fakültesi mecmuası

Language(s) - English

Resource type - Journals

ISSN - 0365-8104

DOI - 10.1501/tipfak_0000000956

Subject(s) - positron emission tomography , medicine , radiology , disease , pathology

1 Hacettepe University Medical Faculty Department of Thoracic Surgery 2 Bülent Ecevit University Medical Faculty Department of Thoracic Surgery 3 Sivas Numune Hospital Department of Thoracic Surgery 4 Hacettepe University Medical Faculty Department of Pathology Gestational trophoblastic neoplasms (GTN) originate from placental tissue and usually metastasizes because of its propensity for early vascular invasion. Intracranial metastases are relatively uncommon. There are limited data on the efficacy of 18-fluorodeoxyglucose positron emission tomography (FDG-PET) in the evaluation of metastatic GTN. We present a case of GTN with simultaneous pulmonary and cranial metastases in which the cranial metasteses were undetectable with positron emission tomography (PET) scan.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research